A pump from Johnson & Johnson (JNJ) automatically calculated and delivered the right amount of insulin to patients with Type 1 diabetes at night in a study involving 20 adults. The diabetics' blood-sugar levels were in the recommended range for over 90% of the night. The subjects were under supervision on an overnight visit to testing facilities during the study; J&J plans to conduct another of these feasibility trials before starting evaluations in which the patients use the device at home. (See Medtronics pump)
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Benzinga.com (Feb 23, 2015)
at Nasdaq.com (Feb 19, 2015)
at Nasdaq.com (Feb 17, 2015)
at Nasdaq.com (Feb 10, 2015)
at Investor's Business Daily (Jan 20, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs